Product Information
ONDANSETRON ODT 4 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1208 per EA under NDC 62756024064. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 2, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756024064
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ONDANSETRONApproval Type
Generic (ANDA)
FDA Application
ANDA077557FDA Approved
8/2/2007
TE Code
AB
On Market Since
8/2/2007
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON ODT 4 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 75.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1208 per EA |
|---|---|
| All-time high | $0.7169 (Feb 12, 2014) |
| All-time low | $0.1208 (Aug 19, 2026) |
| 52-week high | $0.1631 |
| 52-week low | $0.1208 |
| Median price | $0.2559 |
| Average price | $0.3055 |
| Largest weekly change | -35.9% (Aug 19, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-5.4%
6M
-19.5%
1Y
-25.9%
3Y
-33.9%
5Y
-46.1%
All
-75.3%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ondansetron market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON ODT 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON ODT 4 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1208 per EA (NDC 62756024064), effective Aug 19, 2026.
How has the price of ONDANSETRON ODT 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON ODT 4 MG TABLET has declined 75.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ONDANSETRON ODT 4 MG TABLET?
Since Nov 28, 2013, the NADAC for ONDANSETRON ODT 4 MG TABLET has ranged from a low of $0.1208 (Aug 19, 2026) to a high of $0.7169 (Feb 12, 2014), with a median of $0.2559 per EA.
Are there cheaper alternatives to ONDANSETRON ODT 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ONDANSETRON ODT 4 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONDANSETRON ODT 4 MG TABLET?
ONDANSETRON ODT 4 MG TABLET (NDC 62756024064) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.